Showing results (791-800 of 928) with videos related to

Sort By:
Pageof 93
The American Journal of Tropical Medicine and Hygiene|March 3, 2004
Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic chagas heart diseaseAlejandro G Schijman, Carlos A Vigliano, Rodolfo J Viotti, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 13, 2020
Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older AdultsKenneth E Schmader, Myron J Levin, Michael Chen, et al.
Infectious Diseases and Therapy|May 4, 2024
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER TrialsMyron J Levin, Andrew Ustianowski, Stephane De Wit, et al.
Annals of Surgery|June 1, 1974
The relationship of circulating endogenous endotoxin to hemorrhagic shock in the baboonC M Herman, A R Kraft, K R Smith, et al.
The New England Journal of Medicine|March 1, 1990
The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium dietR H Grimm, J D Neaton, P J Elmer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2007
Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantationM Diez, L Favaloro, A Bertolotti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 21, 2006
Retinal dysfunction in patients with chronic Chagas' disease is associated to anti-Trypanosoma cruzi antibodies that cross-react with rhodopsinSilvia C Matsumoto, Vivian Labovsky, Marcela Roncoroni, et al.
Human Vaccines|August 18, 2009
Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 yearsMark H Einstein, Mira Baron, Myron J Levin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2014
A phase I study of PF-04449913, an oral hedgehog inhibitor, in patients with advanced solid tumorsAndrew J Wagner, Wells A Messersmith, M Naveed Shaik, et al.
The Journal of Infectious Diseases|August 31, 2018
Persistence of Varicella-Zoster Virus Cell-Mediated Immunity After the Administration of a Second Dose of Live Herpes Zoster VaccineAdriana Weinberg, Zoran Popmihajlov, Kenneth E Schmader, et al.
Pageof 93